middle.news
How Genetic Signatures’ $20M Loss Masks a Bold Strategic Pivot and 63% Revenue Surge
10:36pm on Friday 29th of August, 2025 AEST
•
Healthcare
Read Story
How Genetic Signatures’ $20M Loss Masks a Bold Strategic Pivot and 63% Revenue Surge
10:36pm on Friday 29th of August, 2025 AEST
Key Points
Revenue up 62.8% to $15.9 million in FY25
Net loss widened 12.6% to $20.1 million
Leadership and board renewal with new CEO Allison Rossiter
Pivot from in-house instrument development to partnerships with Tecan and Repado
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Genetic Signatures (ASX:GSS)
OPEN ARTICLE